Sampliner R E, Schable C A
Am J Clin Pathol. 1984 Jan;81(1):88-90. doi: 10.1093/ajcp/81.1.88.
IgM predominance of antibody to hepatitis B core antigen (anti-HBc) was determined by a modification of a commercial competitive binding radioimmunoassay in 190 chronic carriers of the hepatitis B surface antigen; 16.8% of the chronic carriers had IgM predominance. The carriers with IgM predominance of anti-HBc were more likely to have elevated aminotransferase levels (25% vs. 11%) and chronic active hepatitis by liver biopsy (4 of 7 vs. 2 of 20) than carriers with IgG predominance. IgM predominance of anti-HBc may be an indication of more severe liver involvement in chronic hepatitis B infection.
采用一种改良的商业竞争性结合放射免疫测定法,对190例乙型肝炎表面抗原慢性携带者检测乙型肝炎核心抗原抗体(抗-HBc)的IgM优势情况;16.8%的慢性携带者存在IgM优势。与IgG优势的携带者相比,抗-HBc具有IgM优势的携带者更易出现转氨酶水平升高(25%对11%),且经肝活检显示为慢性活动性肝炎的比例更高(7例中有4例,而20例中有2例)。抗-HBc的IgM优势可能表明慢性乙型肝炎感染时肝脏受累更为严重。